| Waktu | Ballroom 1 (WEST) | Waktu | Ballroom 2 (EAST) |
| 07.30 – 08.30 | MTE 1
Rivaroxaban Across the Thrombotic Spectrum: AF and VTE Panelis :
1. Dr. dr. M. Yamin, SpJP(K), SpPD
2. Dr. dr. Birry Karim, SpPD, Subsp.Kv.(K) Case presenter : dr. Lingga Suryakusumah, SpPD | 07.30 – 08.30 | MTE 2
CCS with refractory angina : the role of Non-Invasive Bypass- External Counterpulsator Panelis :
1. Dr. dr. Charles Limantoro, SpPD, Subsp.Kv(K)
2. dr. Christopher, SpPD, Subsp.Kv(K) Case presenter : dr. Christopher, SpPD, Subsp.Kv(K) |
| 08.30 – 09.00 | OPENING CEREMONY |
| 09.00 – 09.15 | PLENARY LECTURE
The Future of Interventional Cardiology in 2030 : Where Artificial Intelligence Meets Human Expertise
Pembicara : Prof. Dr. dr. Teguh Santoso, SpPD, Subsp.KV(K), Sp.JP, Ph.D, FACC |
| 09.15 – 09.30 | COFFEE BREAK |
| 09.30 – 10.30 | Simposium 1 A to Z: Optimizing Cardiovascular Care to Improve Patients’ Outcome | 09.30 – 10.30 | Simposium 2 Comprehensive Cardiovascular Risk Management: Enhancing Outcomes Through Optimal Hypertension and VTE Care |
| 09.30 – 09.35 | Moderator : dr. Yudistira Panji Santoso, SpPD, Subsp.KV.(K) | 09.30 – 09.35 | Moderator : Dr. dr. Lies Dina Liastuti, Sp. J.P, Subsp. Eko. (K), MARS |
| 09.35 – 09.55 | Topic : Redefining GDMT: The Role of SGLT2i in Heart Failure
Speaker : Prof. Dr. dr. Idrus Alwi, SpPD, Subsp.KV.(K) | 09.35 – 09.55 | Topic : Optimizing Hypertension Control Through Flexible Single-Pill Combination Strategies Across Clinical Stages
Speaker : Dr. dr. Ika Prasetya Wijaya, SpPD, Subsp.Kv(K) |
| 09.55 – 10.15 | Topic : The Evolving Role of Statin in Cardiovascular Events Prevention: Translating Evidence into Practice
Speaker : Dr. dr. Todung D.A Silalahi, SpPD, Subsp.KV.(K) | 09.55 – 10.15 | Topic : Optimizing VTE Management with Apixaban: From Acute Treatment to Long-Term Prevention
Speaker : Dr. dr. Sally Aman Nasution, SpPD, Subsp.Kv(K) |
| 10.15 – 10.30 | Diskusi | 10.15 – 10.30 | Diskusi |
| 10.30 – 11.30 | Simposium 3
Heart Failure Reloaded: Congestion, Kidney, and Complexity | 10.30 – 11.30 | Simposium 4
Current Advances in Antiplatelet Therapy for ACS : Translating Evidence into Clinical Practice |
| 10.30 – 10.35 | Moderator : Dr. dr. Ika Prasetya Wijaya, SpPD, Subsp.KV(K) | 10.30 – 10.35 | Moderator : dr. Rachmat Hamonangan, SpPD, Subsp.Kv(K) |
| 10.35 – 10.55 | Topic : Cardiovascular and Heart Failure Outcomes with SGLT2 Inhibition: Practical Implementation of Dapagliflozin in Modern Cardiology Care
Speaker : Dr. dr. Birry Karim, SpPD, Subsp.KV(K) | 10.35 – 10.55 | Topic : P2Y12 Inhibitors in Real-world Asia: Evidence vs Daily Practicec Speaker : Prof. Dr. dr. Idrus Alwi, Sp.PD,Subsp.KV(K) |
| 10.55 – 11.15 | Topic : The Role of Levamlodipine in Hypertension Management: Efficacy and Safety in Modern Therapy
Speaker : Dr. dr. Eka Ginanjar, SpPD, Subsp.KV(K), MARS, SH | 10.55 – 11.15 | Topic : Early Withdrawal of aspirin De-escalation or Compromise?
Speaker : Dr. dr. Dede Moeswir, SpPD, Subsp.KV(K) |
| 11.15 – 11.30 | Diskusi | 11.15 – 11.30 | Diskusi |
| 11.30 – 12.30 | Lunch Symposium –
From Complex Coronary to Structural Heart Disease: advancing new generation cardiac intervention
Moderator :
Dr. dr. Eka Ginanjar, SpPD, Subsp. Kv(K), MARS, SH |
| 11.35 – 11.50 | Topic 1 : Meres 100 in Clinical Practice: Early Experience and Clinical Evidance
Speaker 1 : Dr. dr. M. Yamin, SpJP(K), SpPD |
| 11.50 – 12.05 | Topic 2 : Mozec SEB: Real-World Case Experience
Speaker 2 : Dr. dr. Eka Ginanjar, SpPD, Subsp. Kv(K), MARS, SH |
| 12.05 – 12.20 | Topic 3 : Myval : Real-World Clinical Experience
Speaker 3 : Prof. Dr. dr. Teguh Santoso, SpPD, Subsp.KV(K), Sp.JP, Ph.D, FACC |
| 12.20 – 12.30 | Discussion |
| 12.30 – 13.30 | ISHOMA |
| 13.30 – 13.35 | Simposium 5
Integrating Care in Hypertension and Dyslipidemia Treatment | 13.30 – 14.30 | Simposium 6
The Vulnerable Plaque: the Real Villain in acute and chronic Coronary Syndromes |
| 13.30 – 13.35 | Moderator : dr. Resultanti, SpPD, Subsp.Kv(K) | 13.30 – 13.35 | Moderator : dr. Marulam M. Panggabean, Sp.PD, Subsp.KV, Sp.JP |
| 13.35 – 13.55 | Topic : Modern AntiHypertensive Therapy; Right Patients, Right Combination,Better Outcomes
Speaker : Dr. dr. Lusiani, SpPD, Subsp.Kv(K), M. Epid | 13.35 – 13.55 | Topic : Vulnarable Plaque Imaging
Speaker : dr. Nuraini Yasmin Kusumawardhani, Sp. PD, Subsp. Kv(K), SpJP |
| 13.55- 14.15 | Topic : Intensify Early, Protect Longer : The Benefit of Combining Rosuvastatin–Ezetimibe for Reaching LDL-C Targets Faster
Speaker : Dr. dr. Dono Antono, SpPD, Subsp.KV.(K) | 13.55- 14.15 | Topic : Unveiling the vulnarable plaque : pushing the limits of high intensity statin
Speaker : Dr. dr. Dede Moeswir, SpPD, Subsp.KV(K) |
| 14.15 – 14.30 | Diskusi | 14.15 – 14.30 | Diksusi |
| 14.30 – 14.45 | COFFEE BREAK | | |
| 14.45 – 15.45 | Simposium 7
Optimizing FFR in CCS with intermediate Lesions : Balancing Clinical Excellence and Cost Effectiveness in the BPJS Era | 14.45 – 15.45 | Simposium 8
APL – Tawada
Update Cardiovascular Therapy : From Drug to the Device |
| 14.45 – 14.50 | Moderator : Dr. dr. Eka Ginanjar, SpPD, Subsp.Kv(K), MARS, SH | 14.45 – 14.50 | Moderator : Dr. dr. Arif Mansjoer, Sp.PD, Subsp.Kv.(K), Subsp.T.I, M.Epid |
| 14.50 – 15.10 | Topic : Revascularization Guidance From the Latest Guideline : Anatomical and Functional Assessment
Speaker : dr. M. Ikhsan, SpPD, Subsp.Kv(K) | 14.50 – 15.10 | Topic : Breaking the Cycle: Obesity Intervention in Cardiovascular Disease
Speaker : Dr. dr. Birry Karim, SpPD, Subsp.Kv(K) |
| 15.10 – 15.30 | Topic :Navigating Revascularization Challenges in the BPJS Era
Speaker : dr. Didi Kurniadhi, SpPD, Subsp.Kv(K) | 15.10 – 15.30 | Topic : Emerging Technology in Pacing Therapy
Speaker : Dr. dr. M. Yamin, SpJP(K), SpPD |
| 15.30 – 15.45 | Diskusi | 15.30 – 15.45 | Diskusi |
| 19.00 – 21.00 | Dinner Symposium
Lower for longer with Inclisiran : First in class lipid lowering therapy
Moderator : dr. Muhadi, SpPD, Subsp.Kv(K), M. Epid Speaker 1 : Dr. dr. Todung Donald Aposan Silalahi, SpPD, Subsp.Kv(K), FINASIM, FICA, FAPSIC
Topic 1 : Inclisiran reinventing LDL-C management in ASCVD Speaker 2 : Dr. dr. Birry Karim, SpPD, Subsp.Kv(K)
Topic 2 : Inclisiran translating lipid guidelines to clinical impact |
